Cardiovascular Effects of Intrathecal Hyperbaric Prilocaine or Bupivacaine in Surgery Under Spinal Anesthesia
Spinal Anesthesia, Cardiac Toxicity
About this trial
This is an interventional diagnostic trial for Spinal Anesthesia focused on measuring Hyperbaric Bupivacaine, Hyperbaric Prilocaine, Non-Invasive Hemodynamic Assessment, Clear Sight Edwards, Cardiac Ultrasound, Cardiac Output, Stroke Volume Variation
Eligibility Criteria
Inclusion Criteria: Male 165 cm < x < 180 cm Aged of 18 or more and less than 65 Elective surgery under spinal anesthesia American Society of Anesthesiology (ASA) I or II Exclusion Criteria: History of heart disease: ischemic or valvular Atrial fibrillation Cardiotropic medication Cardiovascular disease history Norepinephrine uptake medication Urgent surgery History of narrow spinal canal Hemostasis abnormalities or local skin infection Hypersensitivity to local anesthetics Failure of spinal anesthesia leading to plan change during surgery Patient's refusal
Sites / Locations
- Saint Pierre University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Group 1: Hyperbaric Bupivacaine
Group 2: Hyperbaric Prilocaine